[Entecavir: a new hope for the treatment of chronic hepatitis B]

Gastroenterol Hepatol. 2007 May;30(5):285-93. doi: 10.1157/13101981.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Alanine Transaminase / blood
  • Antiviral Agents / adverse effects
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Aspartate Aminotransferases / blood
  • DNA, Viral / blood
  • Double-Blind Method
  • Drug Resistance, Viral
  • Guanine / adverse effects
  • Guanine / analogs & derivatives*
  • Guanine / pharmacology
  • Guanine / therapeutic use
  • HIV Infections / complications
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / genetics
  • Hepatitis B virus / isolation & purification
  • Hepatitis B, Chronic / blood
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / pathology
  • Hepatitis B, Chronic / surgery
  • Humans
  • Lamivudine / therapeutic use
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / pathology
  • Liver Transplantation
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Treatment Outcome
  • Viremia / drug therapy

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B e Antigens
  • Lamivudine
  • entecavir
  • Guanine
  • Aspartate Aminotransferases
  • Alanine Transaminase